Mariana Oncology
100 Forge, 6th Floor,
Watertown MA 02472
For Media:
sarah@argotpartners.com
For Investors:
leo@argotpartners.com
News & Media
Follow us on our journey as we harness the power of radiopharmaceutical technology to take on cancer’s toughest tumors. This journey has brought us to a new name: We are now Mariana Oncology
Check back here for the latest on Mariana Oncology.
Mariana Oncology Announces $175 Million Series B Financing
Financing round led by Deep Track Capital and Forbion with participation from a syndicate of leading biotechnology investors Proceeds to support advancement of novel portfolio of precision, next-generation radiopharmaceuticals and transition into a clinical-stage company WATERTOWN, Mass., September 7, 2023 – Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to…
05/09/23
Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer
08/17/22
Mariana Oncology Recognized as a 2022 Prix Galien USA Nominee for Prix Galien Startup
03/08/22
Mariana Oncology Appoints Karen Smith, M.D., Ph.D., as Independent Board Director
02/07/22
Mariana Oncology Expands Radiopharmaceutical Expertise with Appointment of Bernard Lambert, Ph.D. as Chief Technology Officer
02/03/22
Mariana Oncology Appoints Kapil Dhingra, MBBS, to Board of Directors
12/01/21
Mariana Oncology Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals